All the news Showing 10 of 76 articles.Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Organ wait list shortcut: Patients accepting kidneys, hearts infected with hepatitis C USA Today / 18 September 2018 HCV-Positive Organs: A Viable Option for Uninfected Transplant Patients Healio / 16 September 2018 Liver transplants 'may be unnecessary thanks to new drug treatment' BBC / 17 August 2018 New hepatitis C drugs mean diseased organs can be used for transplants Philly.com / 15 August 2018 Advent of DAAs accompanied by dramatic improvement in survival after HCV-related liver transplant Michael Carter / 18 July 2018 Survival among people with hepatitis C virus (HCV) undergoing liver transplant has improved significantly since the introduction of direct-acting antivirals (DAAs), investigators from Catalonia report in the Journal of Hepatology. Thanks to DAAs, there ... Hepatitis C-infected organ transplants offer hope The Lancet (requires free registration) / 22 June 2018 Direct-acting antivirals bring fewer HCV-related liver transplants, better survival after transplantation, in Europe Michael Carter / 16 April 2018 There has been a steep fall in the number of hepatitis C virus (HCV)-related liver transplants since the introduction of direct-acting antivirals (DAAs), according to European research presented to the ... Surgeons plan to use hepatitis-infected hearts to slash wait for a transplant STAT / 15 May 2017 HCV treatment allows one in four people to come off the transplant waiting list Keith Alcorn / 24 April 2017 Around one in four people with hepatitis C and decompensated cirrhosis came off the transplant waiting list in Europe after direct-acting antiviral treatment, and very few had any subsequent liver-related ... DAA therapy cures most people with HIV/HCV co-infection with decompensated cirrhosis or liver transplants Liz Highleyman / 07 March 2017 People with HIV/hepatitis C virus (HCV) co-infection with liver cirrhosis or liver failure, and those who received liver transplants, saw high rates of sustained virological response using interferon-free direct-acting antiviral (DAA) therapy for ... ← Prev12345...8Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive